Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sam Polesie, Farzad Alinaghi & Alexander Egeberg. (2023) A systematic review investigating at what proportion clinical images are shared in prospective randomized controlled trials involving patients with psoriasis and biological agents. Journal of Dermatological Treatment 34:1.
Read now
Read now
Luca Mastorino, Lorenza Burzi, Giada Frigatti, Alessandra Fazio, Valentina Celoria, Nicole Macagno, Francois Rosset, Stefania Ginevra Passerini, Gabriele Roccuzzo, Anna Verrone, Elena Stroppiana, Michela Ortoncelli, Paolo Dapavo, Pietro Quaglino & Simone Ribero. (2023) Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study. Expert Opinion on Biological Therapy 23:9, pages 929-936.
Read now
Read now
Bénédicte Caron, Jean-Yves Jouzeau, Pierre Miossec, Nadine Petitpain, Pierre Gillet, Patrick Netter & Laurent Peyrin-Biroulet. (2022) Gastroenterological safety of IL-17 inhibitors: a systematic literature review. Expert Opinion on Drug Safety 21:2, pages 223-239.
Read now
Read now
Articles from other publishers (6)
Joseph F. Merola, Lawrence Charles Parish, Lyn Guenther, Charles Lynde, Jean-Philippe Lacour, Petra Staubach, Sue Cheng, Maria Paris, Hernan Picard, Cynthia Deignan, Shauna Jardon, Mindy Chen & Kim A. Papp. (2023) Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial. Journal of the American Academy of Dermatology.
Crossref
Crossref
Emilie Sbidian, Anna Chaimani, Robin Guelimi, Ignacio Garcia-Doval, Camille Hua, Carolyn Hughes, Luigi Naldi, Maria Kinberger, Sivem Afach & Laurence Le Cleach. (2023) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews 2023:7.
Crossref
Crossref
Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo & Mario Valenti. (2023) Anti-IL17 and anti-IL23 biologic drugs for genital psoriasis: a single-center retrospective comparative study. Dermatology Reports.
Crossref
Crossref
W.I. van der Meijden, M.J Boffa, B. ter Harmsel, G. Kirtschig, F. Lewis, M. Moyal‐Barracco, G.‐S. Tiplica & J. Sherrard. (2022) 2021 European guideline for the management of vulval conditions. Journal of the European Academy of Dermatology and Venereology 36:7, pages 952-972.
Crossref
Crossref
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach & Laurence Le Cleach. (2022) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews 2022:8.
Crossref
Crossref
Evgeny V. Sokolovskiy & Muza M. Kokhan. (2021) Clinical evidence of therapy for genital psoriasis by biologic agents. Vestnik dermatologii i venerologii 97:2, pages 50-55.
Crossref
Crossref